Ledger.Open graph →
SEC Form D · filed February 22, 2018

Unleash Immuno Oncolytics, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ST. LOUIS, MO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Ariel Muslera · St. Louis, MODirectorRicardo Lisandro Bril · St. Louis, MODirectorDaniel Katzman · Pleasanton, CAExec · DirectorBolten Charles · St. Louis, MODirectorAriel Muslera · St. Louis, MODirectorRicardo Lisandro Bril · St. Louis, MODirectorDaniel Katzman · St. Louis, MOExec · DirectorBolten Charles · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗